Dannals R F, Långström B, Ravert H T, Wilson A A, Wagner H N
Divisions of Nuclear Medicine and Radiation Health Sciences, Johns Hopkins Medical Institutions, Baltimore, MD 21205-2179.
Int J Rad Appl Instrum A. 1988;39(4):291-5. doi: 10.1016/0883-2889(88)90018-4.
Dexetimide (Fig. 1a), a potent muscarinic cholinergic receptor antagonist, and levetimide (Fig. 1b), its pharmacologically inactive enantiomer, were labeled with 11C for non-invasive in vivo studies of muscarinic cholinergic receptors in the human brain using positron emission tomography. The syntheses were completed in approximately 32 min using [alpha-11C]benzyl iodide as the precursor. The synthesis, purification, characterization and determination of specific activity are presented and discussed.
右美托咪定(图1a)是一种强效毒蕈碱型胆碱能受体拮抗剂,其药理活性无活性对映体左旋托咪定(图1b)用11C标记,用于使用正电子发射断层扫描对人脑海毒蕈碱型胆碱能受体进行非侵入性体内研究。使用[α-11C]苄基碘作为前体,合成在约32分钟内完成。介绍并讨论了合成、纯化、表征和比活度的测定。